BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Phenobarbital
,
rs4950928
,
PRKCA
,
Metabolism of xenobiotics
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
arsenic trioxide
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
PML
SLC7A11
MT1E
HSP26
HSPA6
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
ribosome biogenesis
ribonucleoprotein complex biogenesis
preribosome
nucleolus
cellular nitrogen compound biosynthetic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cultured human lung epithelial cells gene expression following chronic arsenic exposure
Expression data from human Jurkat T cells exposed to 31 compounds
Drug target sets for approved compounds
Arsenite stress response in Saccharomyces cerevisiae
Multiple myeloma cell lines treated with arsenic and darinaparsin
Explore Curated Studies Results
Literature
Most Relevant Literature
Arsenic trioxide: an ancient drug revived.
Inhibition of AKT enhances mitotic cell apoptosis induced by arsenic trioxide.
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.
Hepatotoxicity from arsenic trioxide for pediatric acute promyelocytic leukemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Arsenic Trioxide for Structural p53 Mutations
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART
Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ